Meropenem
- Product NDC
- 44567-402
- 11-digit product format
- 445670402
- Labeler code
- 44567
- Product ID
- 44567-402_65ec9fc3-b50a-481f-8fe4-011b0c848503
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Meropenem
- Dosage form
- INJECTION, POWDER, FOR SOLUTION
- Route
- INTRAVENOUS
- Labeler
- WG Critical Care, LLC
- Application
- NDA215212
- Marketing category
- NDA
- Marketing start
- 2023-09-08
- Substance
- MEROPENEM
- Active strength
- 2 g/1
- Pharmacologic classes
- Carbapenems [CS], Penem Antibacterial [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Meropenem
- Listing expiration
- 2027-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| MEROPENEM | 2 g/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | FV9J3JU8B1 |
| Rxcui | 2664894 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 44567-402-01 | Meropenem | 1 in 1 VIAL | INJECTION, POWDER, FOR SOLUTION | 1 | | 4 |
| 44567-402-06 | Meropenem | 6 in 1 CARTON | INJECTION, POWDER, FOR SOLUTION | 6 | | 4 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 44567-402 | MEROPENEM INJECTION, POWDER, FOR SOLUTION [WG CRITICAL CARE, LLC] | 3 | Current NDC, 2 package rows | 20231103_240325ba-47a8-4ad1-bcab-6772069ee790.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 44567-402-01 | 44567040201 | 1 in 1 VIAL | | | | | Historical |
| 44567-402-06 | 44567040206 | 6 VIAL in 1 CARTON (44567-402-06) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (44567-402-01) | 6 vial | 2023-09-08 | No | No | Current |